Literature DB >> 7251895

Faecal toxin and severity of antibiotic-associated pseudomembranous colitis.

D W Burdon, R H George, G A Mogg, Y Arabi, H Thompson, M Johnson, J Alexander-Williams, M R Keighley.   

Abstract

The relationship between faecal toxin titre, histological evidence of pseudomembrane in the rectum, and severity of antibiotic-associated colitis has been analysed from data on 62 patients whose faeces contained Clostridium difficile toxin. There was a significant correlation between a toxin titre of 6400 or more and the presence of pseudomembrane (p less than 005). There was no correlation between toxin titre, duration of diarrhoea, total white cell count, temperature, serum albumin or serum orosomucoid concentrations. There was, however, a significant correlation between the presence of rectal pseudomembrane and duration of diarrhoea (p less than 0.005). Exposure to clindamycin or lincomycin was also associated with a significantly higher toxin titre than that seen in patients who were given other antibiotics. The duration of diarrhoea of diarrhoea was not longer and rectal pseudomembrane did not occur more often in the patients who had received clindamycin or lincomycin.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7251895      PMCID: PMC493340          DOI: 10.1136/jcp.34.5.548

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  8 in total

1.  Oral metronidazole in Clostridium difficile colitis.

Authors:  N L Pashby; R P Bolton; R J Sherriff
Journal:  Br Med J       Date:  1979-06-16

2.  Antibiotic associated pseudomembranous colitis with negative proctosigmoidoscopy examination.

Authors:  F J Tedesco
Journal:  Gastroenterology       Date:  1979-08       Impact factor: 22.682

3.  Pseudomembranous colitis.

Authors:  A B Price; D R Davies
Journal:  J Clin Pathol       Date:  1977-01       Impact factor: 3.411

4.  Identification of Clostridium difficile as a cause of pseudomembranous colitis.

Authors:  R H George; J M Symonds; F Dimock; J D Brown; Y Arabi; N Shinagawa; M R Keighley; J Alexander-Williams; D W Burdon
Journal:  Br Med J       Date:  1978-03-18

5.  A micro-method for detecting toxins in pseudomembranous colitis.

Authors:  R H George
Journal:  J Clin Pathol       Date:  1979-03       Impact factor: 3.411

6.  Antibiotic-associated colitis--a review of 66 cases.

Authors:  G A Mogg; M R Keighley; D W Burdon; J Alexander-Williams; D Youngs; M Johnson; S Bentley; R H George
Journal:  Br J Surg       Date:  1979-10       Impact factor: 6.939

7.  Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia.

Authors:  J G Bartlett; T W Chang; M Gurwith; S L Gorbach; A B Onderdonk
Journal:  N Engl J Med       Date:  1978-03-09       Impact factor: 91.245

8.  Randomised controlled trial of vancomycin for pseudomembranous colitis and postoperative diarrhoea.

Authors:  M R Keighley; D W Burdon; Y Arabi; J A Williams; H Thompson; D Youngs; M Johnson; S Bentley; R H George; G A Mogg
Journal:  Br Med J       Date:  1978-12-16
  8 in total
  22 in total

Review 1.  Clostridium difficile toxins: mechanism of action and role in disease.

Authors:  Daniel E Voth; Jimmy D Ballard
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

2.  Analysis of latex agglutination test for Clostridium difficile toxin A (D-1) and differentiation between C difficile toxins A and B and latex reactive protein.

Authors:  S P Borriello; F E Barclay; P J Reed; A R Welch; J D Brown; D W Burdon
Journal:  J Clin Pathol       Date:  1987-05       Impact factor: 3.411

3.  Effects of Clostridium difficile toxins A and B in rabbit small and large intestine in vivo and on cultured cells in vitro.

Authors:  A A Lima; D M Lyerly; T D Wilkins; D J Innes; R L Guerrant
Journal:  Infect Immun       Date:  1988-03       Impact factor: 3.441

4.  Simplified procedure for tissue culture in routine detection of cytotoxins.

Authors:  A R Welch; S P Borriello; F E Barclay
Journal:  J Clin Pathol       Date:  1985-07       Impact factor: 3.411

5.  Lincomycin increases the half-life of beta-lactamase mRNA.

Authors:  O Matsushita; A Okabe; H Hayashi; Y Kanemasa
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

6.  Clostridium difficile toxin B-induced colonic inflammation is mediated by the FOXO3/PPM1B pathway in fetal human colon epithelial cells.

Authors:  Qingqing Xu; Ying Li; Yuejuan Zheng; Yijian Chen; Xiaogang Xu; Minggui Wang
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

7.  Clostridium difficile and cytotoxin in routine faecal specimens.

Authors:  J Q Nash; B Chattopadhyay; J Honeycombe; S Tabaqchali
Journal:  J Clin Pathol       Date:  1982-05       Impact factor: 3.411

Review 8.  Clostridium difficile infection: a common clinical problem for the general internist.

Authors:  G M Caputo; M R Weitekamp; A E Bacon; C Whitener
Journal:  J Gen Intern Med       Date:  1994-09       Impact factor: 5.128

9.  The impact of pseudomembrane formation on the outcome of Clostridium difficile-associated disease.

Authors:  T Berdichevski; N Keller; G Rahav; S Bar-Meir; R Eliakim; S Ben-Horin
Journal:  Infection       Date:  2013-05-26       Impact factor: 3.553

10.  Nosocomial diarrhoeas in a surgical division hyperendemic for Clostridium difficile: epidemiologic aspects emerging from an analysis of clinical records.

Authors:  P Urbano; S Le Brun
Journal:  Eur J Epidemiol       Date:  1986-12       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.